Universe Pharmaceuticals (NASDAQ:UPC) Stock Price Up 0.4% – Time to Buy?

Universe Pharmaceuticals INC (NASDAQ:UPC)’s stock price rose 0.4% on Tuesday. The stock traded as high as $4.83 and last traded at $4.66. 13,497 shares traded hands during trading, a decline of 96% from the average daily volume of 335,508 shares. The stock had previously closed at $4.64.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Wall Street Zen raised Universe Pharmaceuticals to a “hold” rating in a report on Saturday, August 29th. Weiss Ratings upgraded shares of Universe Pharmaceuticals from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

Universe Pharmaceuticals Stock Down 0.2%

The company has a debt-to-equity ratio of 0.04, a current ratio of 4.05 and a quick ratio of 3.90. The stock has a 50-day moving average price of $4.81 and a 200-day moving average price of $3.87.

Universe Pharmaceuticals (NASDAQ:UPC) last posted its quarterly earnings results on Wednesday, July 29th. The company reported ($1.38) earnings per share for the quarter. The company had revenue of $4.52 million during the quarter.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals Inc (NASDAQ: UPC) is a China-based pharmaceutical and healthcare products company. The company develops, manufactures and markets pharmaceutical products, health supplements and medical devices, with an emphasis on traditional Chinese medicine and other products used in everyday healthcare.

Its product portfolio includes over-the-counter and prescription medicines designed to address a range of conditions, including respiratory, cardiovascular, digestive and dermatological ailments.